HistoSonics has received the FDA approval for histotripsy, which is a technique that uses targeted ultrasound waves to break down tumors in humans for liver treatment. HistoSonics was co-founded by Zhen Xu, University of Michigan Professor and Vice President Ultrasonics, UFFC-S.
Read More
